FDA may at any time require
manufacturers of licensed biological products to submit to FDA
samples of any lot with the protocols showing the results of the
applicable tests prior to distributing the lot of the product.
Samples and protocols are required by FDA to help ensure the
safety, purity and potency of the product because of thdue to the
potential of lot-to-lot variability of a product produced from
living organisms.
US Code:
42
USC 262 Name of Law: Public Health Service Act
ILa Mizrachi 301 796-7726
ila.mizrachi@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.